SCHEMBL14249149

SCHEMBL14249149

O=c1ncccn2cccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 5/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
TDP2 O95551 1/20 0.35
NSD2 O96028 1/20 0.35
ABL1 P00519 1/20 0.35
PLCG1 P19174 1/20 0.35
CES1 P23141 1/20 0.35
PAX8 Q06710 1/20 0.35
RIN1 Q13671 1/20 0.35
THRB P10828 1/20 0.35
BLM P54132 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
DAO P14920 1/20 0.35
RPS6KA5 O75582 1/20 0.34
KDM4E B2RXH2 5/20 0.34
ALDH1A1 P00352 5/20 0.34
HPGD P15428 4/20 0.34
GLA P06280 2/20 0.34
HSD17B10 Q99714 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22367279 0.72 PDE10A (0.41) KDM4EHPGDHSD17B10MAPT
SCHEMBL16151417 0.70 PARP1 (0.39) GAAKMT2AMEN1DAOALDH1A1
SCHEMBL30790918 0.70 PARP1 (0.39) GAAKMT2AMEN1DAOALDH1A1
SCHEMBL65195 0.67
SCHEMBL1870141 0.65 MAPT (0.50) KMT2AMEN1BLMRPS6KA5KDM4E
SCHEMBL25528102 0.65 ALDH1A1 (0.34) GAAKMT2AMEN1KDM4EALDH1A1
SCHEMBL27769891 0.65
SCHEMBL10514874 0.65 ALOX15 (0.46) GAAKMT2AMEN1KDM4EALDH1A1
SCHEMBL9181834 0.65 KDM4E (0.33) GAARPS6KA5KDM4EALDH1A1HPGD
SCHEMBL397662 0.65 NUDT1 (0.50) GAAKMT2AKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4584250-A1 COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS Biohaven Therapeutics Ltd. (VG) 2025-07-16 EP disclosed
WO-2024054811-A1 COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS BIOHAVEN THERAPEUTICS LTD. (VG) 2024-03-14 WO disclosed
WO-2012172093-A1 DIHYDROINDOLIZINE DERIVATE AS METABOTROPIC GLUTAMATE RECEPTOR MODULATORS MERZ PHARMA GMBH & CO. KGAA (DE) 2012-12-20 WO disclosed